Little T, I absolutely agree about the lack of appreciation from Mr Market. However, I think results will be known earlier than 15 months. Assuming they will announce the results of the Lillac study, then;
1. Enrollments should be complete by mid 2020 (as states by Serge),
2. If some have already completed Lillac, then the period of time from enrollment to commencement is very short,
3. 12 week trial takes us until October or November,
4. Give them 3 months to analyse the results, so we are talking Q1 2021.
This is my view only, and I'd appreciate comments as to why I'm wrong (particularly from WAG). The company is being prudent by not given exact timeframes, but in 12 months I think we will formally know the results. Hence, I dont want to see a rushed ROW deal, nor a rushed company sale. It will soon either be $20 or $0.1. I'm backing the former.
- Forums
- ASX - By Stock
- NEU
- Ann: 5 Orphan Drug programs and Rett in Phase 3 funded by partner
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.97%
!
$17.29

Ann: 5 Orphan Drug programs and Rett in Phase 3 funded by partner, page-18
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.29 |
Change
0.660(3.97%) |
Mkt cap ! $2.178B |
Open | High | Low | Value | Volume |
$16.80 | $17.34 | $16.63 | $9.078M | 529.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1334 | $17.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.33 | 2245 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1334 | 17.180 |
1 | 1000 | 17.020 |
3 | 693 | 17.000 |
1 | 1600 | 16.950 |
1 | 2000 | 16.930 |
Price($) | Vol. | No. |
---|---|---|
17.330 | 2245 | 3 |
17.340 | 1130 | 2 |
17.380 | 2350 | 2 |
17.400 | 4462 | 3 |
17.430 | 7 | 1 |
Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |